Dr Richard Bagnall is a research leader in the study of human genetic diseases. He defined the genetic causes of the blood clotting disorder, haemophilia A, at King’s College London, UK (PhD) before moving to Sydney. He joined the Molecular Cardiology Program as a Senior Research Officer and now heads the Bioinformatics and Molecular Genetics Group. His current research focus is on understanding how genetic variants cause inherited heart diseases and sudden cardiac death. This is achieved by developing new computational approaches to analyse genome sequencing data and new laboratory-based methods to identify and characterise genetic variants. His research outcomes have a direct translational impact on the patients and families who attend the Hypertrophic Cardiomyopathy and Genetic Heart Diseases Clinics at Royal Prince Alfred Hospital, Sydney. Richard has published his research findings in leading journals including the New England Journal of Medicine and Journal of the American College of Cardiology. He was the inaugural recipient of a Centenary Institute Future Leaders Fellowship (2018) and is funded by a NSW Health Cardiovascular Senior Scientist Grant (2019-2021).